Status:
COMPLETED
Rosehip Powder for Knee Osteoarthritis
Lead Sponsor:
Frederiksberg University Hospital
Collaborating Sponsors:
Axellus
Oak Foundation
Conditions:
Osteoarthritis
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
The aim of this study is to compare three combinations of preparations in a comparative trial program on rosehip powder for knee OA. The trial is a comparative, 12-week, randomized, double-blind, acti...
Detailed Description
Complementary or alternative therapies (incl. nutraceuticals - functional ingredients sold as powders, pills, and other medicinal forms not generally associated with food) for OA are commonly used, an...
Eligibility Criteria
Inclusion
- 40 years of age and have clinical evidence (diagnosed according to the American College of Rheumatology \[ACR\] criteria) and radiographic evidence of OA.
- Eligible patients have a self-reported pain level corresponding to at least 40 mm on a 100 mm VAS when screened
Exclusion
- Patients will not be considered eligible if they are considered morbidly obese -having a body mass index (BMI) above 40 kg/m2, concurrent medical or arthritic conditions that could confound evaluation of the index joint, or coexisting disease that could preclude successful completion of the trial.
- Patients who already take a rosehip powder as a dietary supplement; have inability to speak Danish fluently; or have a mental state impeding compliance with the program will not be considered eligible for inclusion.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01430481
Start Date
August 1 2011
End Date
January 1 2014
Last Update
August 10 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Parker Institute, Frederiksberg Hospital
Frederiksberg, Denmark, 2000